Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles

被引:15
作者
Zitko, Jan [1 ]
Jampilek, Josef [2 ]
Dobrovolny, Lukas [1 ]
Svobodova, Michaela [3 ]
Kunes, Jiri [1 ]
Dolezal, Martin [1 ]
机构
[1] Charles Univ Prague, Fac Pharm Hradec Kralove, Hradec Kralove 50005, Czech Republic
[2] Univ Vet & Pharmaceut Sci, Fac Pharm, Brno 61242, Czech Republic
[3] Reg Hosp, Dept Microbiol, Pardubice 53203, Czech Republic
关键词
Alkyl chain homology; Antimycobacterial activity; Lipophilicity; Pyrazinamide derivatives; Structure-activity relationships; MYCOBACTERIUM-TUBERCULOSIS; PYRAZINOIC ACID; PYRAZINAMIDE; DERIVATIVES;
D O I
10.1016/j.bmcl.2011.12.129
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 14 new compounds related to pyrazinamide were synthesized, characterized with analytical data and screened for in vitro antimycobacterial activity against Mycobacterium tuberculosis, Mycobacterium kansasii and two types of Mycobacterium avium. The series comprised of N-substituted 3-aminopyrazine- 2,5-dicarbonitriles derived from 3-chloropyrazine-2,5-dicarbonitrile by nucleophilic substitution of chlorine by various non-aromatic amines (alkylamines, cycloalkylamines and heterocyclic amines). Noteworthy antimycobacterial activity against M. tuberculosis was found among the alkylamino derivatives, for example, 3-(heptylamino) pyrazine-2,5-dicarbonitrile inhibited M. tuberculosis at MIC = 51 mu mol/L. 3-(Hexylamino) pyrazine-2,5-dicarbonitrile inhibited M. kansasii at MIC = 218 mu mol/L. Basic structure-activity relationships are discussed. A comparison between calculated and experimentally determined lipophilicity parameters within the series is included. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1598 / 1601
页数:4
相关论文
共 18 条
  • [1] New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents
    Ancizu, Saioa
    Moreno, Elsa
    Solano, Beatriz
    Villar, Raquel
    Burguete, Asuncion
    Torres, Enrique
    Perez-Silanes, Silvia
    Aldana, Ignacio
    Monge, Antonio
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (07) : 2713 - 2719
  • [2] Inhibition of M. tuberculosis in vitro in monocytes and in mice by aminomethytene pyrazinamide anatogs
    Chung, Woo Jin
    Kornilov, Andrei
    Brodsky, Benjamin H.
    Higgins, Michael
    Sanchez, Tracy
    Heifets, Leonid B.
    Cynamon, Michael H.
    Welch, John
    [J]. TUBERCULOSIS, 2008, 88 (05) : 410 - 419
  • [3] SYNTHESIS AND H-1 AND C-13 NMR-SPECTRA OF SULFUR DERIVATIVES OF PYRAZINE DERIVED FROM AMIDATION PRODUCT OF 2-CHLOROPYRAZINE AND 6-CHLORO-2-PYRAZINECARBONITRILE - TUBERCULOSTATIC ACTIVITY
    DLABAL, K
    PALAT, K
    LYCKA, A
    ODLEROVA, Z
    [J]. COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 1990, 55 (10) : 2493 - 2501
  • [4] Antimycobacterial Evaluation of Pyrazinoic Acid Reversible Derivatives
    Dolezal, Martin
    Kesetovic, Diana
    Zitko, Jan
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (32) : 3506 - 3514
  • [5] FOKS H, 1977, POL J PHARMACOL PHAR, V29, P61
  • [6] Novel regioselective preparation of 5-chloropyrazine-2-carbonitrile from pyrazine-2-carboxamide and coupling study of substituted phenylsulfanylpyrazine-2-carboxylic acid derivatives
    Jampílek, J
    Dolezal, M
    Kunes, J
    Satínsky, D
    Raich, I
    [J]. CURRENT ORGANIC CHEMISTRY, 2005, 9 (01) : 49 - 60
  • [7] Kerns EH, 2008, DRUG-LIKE PROPERTIES: CONCEPTS, STRUCTURE DESIGN AND METHODS, P1
  • [8] Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives
    Moreno, Elsa
    Ancizu, Saioa
    Perez-Silanes, Silvia
    Torres, Enrique
    Aldana, Ignacio
    Monge, Antonio
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (10) : 4418 - 4426
  • [9] Synthesis, antimycobacterial and antifungal evaluation of 3-arylaminopyrazine-2,5-dicarbonitriles
    Palek, Lukas
    Dvorak, Jaroslav
    Svobodova, Michaela
    Buchta, Vladimir
    Jampilek, Josef
    Dolezal, Martin
    [J]. ARCHIV DER PHARMAZIE, 2008, 341 (01) : 61 - 65
  • [10] Pyrazinamide, but not pyrazinoic acid, is a competitive inhibitor of NADPH binding to Mycobacterium tuberculosis fatty acid synthase I
    Sayahi, Halimah
    Zimhony, Oren
    Jacobs, William R., Jr.
    Shekhtman, Alexander
    Welch, John T.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (16) : 4804 - 4807